Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-11-10 Purchase |
2023-11-13 5:29 pm |
Lyra Therapeutics Inc. | LYRA | Waksal Harlan Executive Chair |
25,000 | $2.9638 | $74,095 | 261,966 (Direct) |
View |
| 2022-04-12 Purchase |
2022-04-13 7:16 pm |
Lyra Therapeutics Inc. | LYRA | Waksal Harlan Executive Chair |
236,966 | $4.22 | $999,997 | 236,966 (Direct) |
View |
| 2021-11-09 Sale |
2021-11-09 5:42 pm |
Kadmon Holdings Inc. | KDMN | Waksal Harlan President, CEO |
177,945 | $9.5 | $1,690,478 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-12-09 Option Award |
2024-12-11 6:39 pm |
N/A N/A |
Lyra Therapeutics Inc. | LYRA | Waksal Harlan Executive Chair |
128,333 | $0 | 0 (Direct) |
View |
Ownership |
2024-06-11 5:52 pm |
N/A N/A |
Perceptive Capital Solutions Corp | PCSC | Waksal Harlan Director |
0 | $0 | 30,000 (Direct) |
View |
| 2024-03-18 Option Award |
2024-03-20 7:21 pm |
N/A N/A |
Lyra Therapeutics Inc. | LYRA | Waksal Harlan Executive Chair |
275,000 | $0 | 536,966 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-02 5:19 pm |
N/A 2033-01-30 |
Lyra Therapeutics Inc. | LYRA | Waksal Harlan Executive Chair |
200,000 | $0 | 200,000 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-21 4:06 pm |
N/A 2032-06-15 |
Lyra Therapeutics Inc. | LYRA | Waksal Harlan Executive Chair |
953,002 | $0 | 953,002 (Direct) |
View |
| 2022-02-16 Option Award |
2022-02-18 5:09 pm |
N/A 2032-02-15 |
Lyra Therapeutics Inc. | LYRA | Waksal Harlan Executive Chair |
520,000 | $0 | 520,000 (Direct) |
View |
| 2021-05-13 Option Award |
2021-05-17 4:05 pm |
N/A N/A |
Kadmon Holdings Inc. | KDMN | Waksal Harlan President, CEO |
25,000 | $3.5591 | 177,945 (Direct) |
View |
| 2021-04-03 Option Award |
2021-04-06 4:25 pm |
2021-04-03 2028-04-03 |
Kadmon Holdings Inc. | KDMN | Waksal Harlan President, CEO |
327,498 | $0 | 982,500 (Direct) |
View |
| 2021-01-08 Option Award |
2021-01-12 4:27 pm |
N/A 2031-01-08 |
Kadmon Holdings Inc. | KDMN | Waksal Harlan President, CEO |
2,000,000 | $0 | 2,000,000 (Direct) |
View |
| 2020-09-10 Option Award |
2020-09-10 5:02 pm |
2020-09-10 2028-04-03 |
Kadmon Holdings Inc. | KDMN | Waksal Harlan President, CEO |
109,167 | $0 | 655,002 (Direct) |
View |